QT Interval Prolongation Associated with Azithromycin/Methadone Combination

被引：0

作者：

Amer, S. ^{[1
]}

Hassan, S. ^{[1
]}

Shariffi, M. ^{[1
]}

Chueca, L. ^{[1
]}

机构：

[1] Henry Ford Hosp, Detroit, MI 48202 USA

来源：

WEST INDIAN MEDICAL JOURNAL | 2013年 / 62卷 / 09期

关键词：

Azithromycin; methadone; QT prolongation; torsades de pointes;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This report documents the occurrence of QT prolongation in a 57-year old man, on methadone replacement therapy, treated with azithromycin for community acquired pneumonia. This case highlights a hitherto unknown drug interaction. In light of ever-increasing use of azithromycin, it is imperative that azithromycin be used with caution in patients who are already on drugs that are known to cause QT prolongation or that cause torsades de pointes.

引用

收藏

页码：864 / 865

页数：2

相关论文

共 50 条

[21] Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 [J].

O'Connell, Thomas F. ;

Bradley, Christopher J. ;

Abbas, Amr E. ;

Williamson, Brian D. ;

Rusia, Akash ;

Tawney, Adam M. ;

Gaines, Rick ;

Schott, Jason ;

Dmitrienko, Alex ;

Haines, David E. .

JACC-CLINICAL ELECTROPHYSIOLOGY, 2021, 7 (01) :16-25

[22] Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation [J].

Alberto Keller, Guillermo ;

Ponte, Marcelo L. ;

Di Girolamo, Guillermo .

CURRENT DRUG SAFETY, 2010, 5 (01) :105-111

[23] Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study [J].

Anchersen, Katinka ;

Clausen, Thomas ;

Gossop, Michael ;

Hansteen, Viggo ;

Waal, Helge .

ADDICTION, 2009, 104 (06) :993-999

[24] QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics [J].

Sanjay Chandrasekhar ;

Michael G. Fradley .

Current Treatment Options in Oncology, 2019, 20

[25] QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France [J].

Perrin-Terrin, Aurelie ;

Pathak, Atul ;

Lapeyre-Mestre, Maryse .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (04) :503-510

[26] Effects of methadone on QT-interval dispersion [J].

Krantz, MJ ;

Lowery, CM ;

Martell, BA ;

Gourevitch, MN ;

Arnsten, JH .

PHARMACOTHERAPY, 2005, 25 (11) :1523-1529

[27] Methadone-associated Q-T interval prolongation and torsades de pointes [J].

Stringer, John ;

Welsh, Christopher ;

Tommasello, Anthony .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (09) :825-833

[28] A case with a trend of QT interval prolongation due to the introduction of methadone to a pancreatic cancer patient on levofloxacin [J].

Ouchi, Ryusuke ;

Nagao, Munenori ;

Suzuki, Shinju ;

Yamagata, Toshihiro ;

Chiba, Mie ;

Kurata, Naoko ;

Usui, Kensuke ;

Watanabe, Takashi ;

Koyama, Kaori ;

Okada, Kouji .

JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01)

[29] A case with a trend of QT interval prolongation due to the introduction of methadone to a pancreatic cancer patient on levofloxacin [J].

Ryusuke Ouchi ;

Munenori Nagao ;

Shinju Suzuki ;

Toshihiro Yamagata ;

Mie Chiba ;

Naoko Kurata ;

Kensuke Usui ;

Takashi Watanabe ;

Kaori Koyama ;

Kouji Okada .

Journal of Pharmaceutical Health Care and Sciences, 10

[30] Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy [J].

Roy, Andrew K. ;

McCarthy, Catherine ;

Kiernan, Gareth ;

McGorrian, Catherine ;

Keenan, Eamon ;

Mahon, Niall G. ;

Sweeney, Brion .

ADDICTION, 2012, 107 (06) :1132-1139

← 1 2 3 4 5 →